These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 31933129

  • 61. Critical attributes of fine excipient materials in carrier-based dry powder inhalation formulations: The particle shape and surface properties.
    Elsayed MMA, Alfagih IM, Brockbank K, Aodah AH, Ali R, Almansour K, Shalash AO.
    Int J Pharm; 2024 Apr 25; 655():123966. PubMed ID: 38452834
    [Abstract] [Full Text] [Related]

  • 62. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations.
    Liu T, Tong S, Liao Q, Pan L, Cheng M, Rantanen J, Cun D, Yang M.
    Int J Pharm; 2023 Mar 25; 635():122702. PubMed ID: 36773729
    [Abstract] [Full Text] [Related]

  • 63. Improving Dry Powder Inhaler Performance by Surface Roughening of Lactose Carrier Particles.
    Tan BM, Chan LW, Heng PW.
    Pharm Res; 2016 Aug 25; 33(8):1923-35. PubMed ID: 27091033
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders.
    Zhang Q, Li Y, Li L, Cheng Y, Yu F, Li R, Hou S.
    AAPS PharmSciTech; 2023 Mar 14; 24(3):78. PubMed ID: 36918500
    [Abstract] [Full Text] [Related]

  • 66. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles.
    Xu Y, Harinck L, Lokras AG, Gerde P, Selg E, Sjöberg CO, Franzyk H, Thakur A, Foged C.
    Int J Pharm; 2022 Jun 10; 621():121758. PubMed ID: 35483619
    [Abstract] [Full Text] [Related]

  • 67. Investigation into alternative sugars as potential carriers for dry powder formulation of budesonide.
    Momin MN, Hedayati A, Nokhodchi A.
    Bioimpacts; 2011 Jun 10; 1(2):105-11. PubMed ID: 23678414
    [Abstract] [Full Text] [Related]

  • 68. Recent developments in lactose blend formulations for carrier-based dry powder inhalation.
    Hebbink GA, Jaspers M, Peters HJW, Dickhoff BHJ.
    Adv Drug Deliv Rev; 2022 Oct 10; 189():114527. PubMed ID: 36070848
    [Abstract] [Full Text] [Related]

  • 69. The Relationship Between the Permeability and the Performance of Carrier-Based Dry Powder Inhalation Mixtures: New Insights and Practical Guidance.
    Shalash AO, Khalafallah NM, Molokhia AM, Elsayed MMA.
    AAPS PharmSciTech; 2018 Feb 10; 19(2):912-922. PubMed ID: 29063377
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
    Young PM, Crapper J, Philips G, Sharma K, Chan HK, Traini D.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr 10; 27(2):138-47. PubMed ID: 24004178
    [Abstract] [Full Text] [Related]

  • 72. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for Inhalation.
    Muddle J, Murnane D, Parisini I, Brown M, Page C, Forbes B.
    J Pharm Sci; 2015 Nov 09; 104(11):3861-3869. PubMed ID: 26220184
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.
    Kaewjan K, Srichana T.
    Pharm Dev Technol; 2016 Nov 09; 21(1):68-75. PubMed ID: 25331092
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Apr 09; 52(4):444-6. PubMed ID: 15056961
    [Abstract] [Full Text] [Related]

  • 80. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M, Kappl M, Butt HJ, Urbanetz NA, Lippold BC.
    Eur J Pharm Biopharm; 2007 Sep 09; 67(2):579-86. PubMed ID: 17418548
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.